Page 69 - Read Online
P. 69

Abdel-Halim et al. Vessel Plus 2022;6:8  https://dx.doi.org/10.20517/2574-1209.2021.40  Page 11 of 14

               The presence of associated skin necrosis, ulceration, and gangrenes in the context of palpable purpuric
               lesions warrants exclusion of other conditions such as hepatitis C virus-induced vasculitis other causes of
               cryoglobulinemic vasculitis and vasculitis associated with underlying vasculopathic disorders such as
                                                              [43]
               protein C and S deficiency or factor V Leiden mutation . Livedo reticularis/racemosa and skin nodules can
               also be a manifestation of polyarteritis nodosa .
                                                      [4]
               Localized cases of GPA involving mainly the face, nose, ears, and throat should be differentiated from
               levamisole induced vasculopathy associated with levamisole-adulterated cocaine abuse. History taking, skin
                                                                            [44]
               biopsy findings, and negative ANCA can help in verifying this condition .
               PG-like lesions of GPA should be differentiated from classic PG. The presence of cytoplasmic/anti-PR3-
               ANCA, the involvement of internal organs (mainly the lungs), the presence of palisaded neutrophilic and
               granulomatous dermatitis, necrotizing vasculitis and basophilic collagen degeneration on skin biopsy, and
               not diffuse neutrophilic infiltrate helps in excluding classic PG in such cases . Cultures to exclude
                                                                                     [45]
               infectious causes are also important in PG-like lesions or in cases presenting with ulcerated nodules/plaques
               that show granulomatous inflammation on biopsy. Finally, many types of cutaneous lymphomas can
               present as PG-like lesions , and a skin biopsy will easily establish the diagnosis.
                                     [46]

               It is important also to remember that lesions of PNGD can occur in association with a wide range of
               systemic disorders other than AAV such as connective tissue disorders, arthritides, Behçet’s disease,
               ulcerative colitis, lymphoproliferative disorders, and multiple sclerosis [15,47,48] . Careful clinical, laboratory, and
               serological assessment is important in such cases.

               Finally, care should be given not to confuse vasculitic lesions of AAV with hemorrhagic or occlusive
               pseudovasculitis. Hemorrhagic pseudovasculitis presents with non-palpable petechiae, purpura, or
               ecchymoses as a result of vessel wall dysfunction that can occur in many conditions such as metabolic
               disorders, nutritional deficiencies, drug reactions, infections, thrombocytopenias, or simply with aging.
               Occlusive  pseudovasculitis  on  the  other  hand  presents  with  livedo,  acral  cyanosis,  or  digital
               necrosis/gangrene as a result of occlusion of vessel lumen by emboli, thrombi, or other materials. Examples
               of occlusive pseudovasculitis include essential cryoglobulinemia, purpura fulminans, coumadin necrosis,
               antiphospholipid syndrome, cardiac myxoma, calciphylaxis, cholesterol embolization, and radiation
               arteritis . In all cases, a skin biopsy and laboratory investigations can easily verify such conditions.
                      [49]

               MANAGEMENT OF CUTANEOUS LESIONS OF AAV
               AAV patients presenting with skin manifestations should follow the same standard algorithms and
               guidelines of management used in patients without cutaneous manifestations. These include measures to
               induce remission of new-onset organ threatening (life threatening) or non-organ threatening disease, as
                                                                                        [50]
               well as measures to induce remissions of relapses and measures to maintain remissions .

               Although skin ulcers if present can become contaminated with different types of bacteria, routine
               administration of topical or systemic antibiotics is not encouraged, as it was not found to be associated with
               reduced bacterial colonization or better healing and can lead to emergence of resistant strains . Systemic
                                                                                               [51]
               and non-topical antibiotics are recommended only in the presence of significant evidence of infection such
               as increasing pain, erythema in the surrounding skin, progressive increase in ulcer size, pus discharge,
               hotness, or edema . Proper management of ulcers should also include removal of necrotic tissue by
                               [52]
               surgical or chemical debridement and the use of appropriate dressings such as hydrocolloid and hydrogel
               sheets which absorb fluids from the wound and keep it moist [53,54] . Pain relief measures should also be
   64   65   66   67   68   69   70   71   72   73   74